RESMED INC — Director's Dealing 2019

Apr 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-04-01

Reporting Person: McHale Richard (President, RC Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-01	ResMed Common Stock	M	244	$58.24	Acquired	23648	Direct
2019-04-01	ResMed Common Stock	S	244	$105.05	Disposed	23404	Direct
2019-04-01	ResMed Common Stock	M	1079	$58.24	Acquired	24483	Direct
2019-04-01	ResMed Common Stock	S	1079	$105.05	Disposed	23404	Direct
2019-04-02	ResMed Common Stock	M	4907	$58.24	Acquired	28311	Direct
2019-04-02	ResMed Common Stock	S	4907	$105.00	Disposed	23404	Direct
2019-04-02	ResMed Common Stock	M	21616	$58.24	Acquired	45020	Direct
2019-04-02	ResMed Common Stock	S	21616	$105.00	Disposed	23404	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-01	Resmed Stock Option Plan	$58.24	M	244	Disposed	2022-11-19	ResMed Common Stock (244)	Direct
2019-04-01	Resmed Stock Option Plan	$58.24	M	1079	Disposed	2022-11-19	ResMed Common Stock (1079)	Direct
2019-04-02	Resmed Stock Option Plan	$58.24	M	4907	Disposed	2022-11-19	ResMed Common Stock (4907)	Direct
2019-04-02	Resmed Stock Option Plan	$58.24	M	21616	Disposed	2022-11-19	ResMed Common Stock (21616)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest 1/3 per year.